CXCR2 and Alzheimer disease: In addition, we found no significant differences in CXCR2 levels in the brain tissue EVs between NC and pathological AD donors, which dismisses the possibility that the variations observed in our results are attributable to the differential expression of CXCR2 under pathophysiological conditions (Fig. S15H).